Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of the American Veterinary Medical Association
|
September 15, 1990
Prekallikrein deficiency in a family of Belgian horses
R J Geor, M L Jackson, K D Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1993
In vivo dimeric association of class I MHC heavy chains. Possible relationship to class I MHC heavy chain-beta 2-microglobulin dissociation
G G Capps, B E Robinson, K D Lewis, et al.
Addictive Behaviors
|
January 1, 1995
An empirical classification of drinking patterns among alcoholics: binge, episodic, sporadic, and steady
E E Epstein, C W Kahler, B S McCrady, et al.
Acta Anaesthesiologica Sinica
|
November 2, 2001
Transesophageal echocardiography in the anesthetic management of total hip arthroplasty
C Johnson, K D Lewis, S N Steen, et al.
Journal of Lipid Research
|
March 1, 1996
Rat hepatoma L35 cells, a liver-differentiated cell line, display resistance to bile acid repression of cholesterol 7 alpha-hydroxylase
J D Trawick, K D Lewis, S Dueland, et al.
Investigational New Drugs
|
March 15, 2012
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
A Dasari, L Gore, W A Messersmith, et al.
MCN. the American Journal of Maternal Child Nursing
|
January 1, 1996
13 nurses tell us, why i'm proud to be an MCH nurse
M Biancuzzo, M K Kachoyeanos, J K Leavitt, et al.
ESMO Open
|
October 29, 2021
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up
S P D'Angelo, S Bhatia, A S Brohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2022
Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAF<sup>V600</sup> mutation-positive melanoma
C Robert, K D Lewis, R Gutzmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF<sup>v600</sup> mutation-positive melanoma receiving adjuvant vemurafenib
P A Ascierto, K D Lewis, A M Di Giacomo, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of the American Veterinary Medical Association
|
September 15, 1990
Prekallikrein deficiency in a family of Belgian horses
R J Geor, M L Jackson, K D Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1993
In vivo dimeric association of class I MHC heavy chains. Possible relationship to class I MHC heavy chain-beta 2-microglobulin dissociation
G G Capps, B E Robinson, K D Lewis, et al.
Addictive Behaviors
|
January 1, 1995
An empirical classification of drinking patterns among alcoholics: binge, episodic, sporadic, and steady
E E Epstein, C W Kahler, B S McCrady, et al.
Acta Anaesthesiologica Sinica
|
November 2, 2001
Transesophageal echocardiography in the anesthetic management of total hip arthroplasty
C Johnson, K D Lewis, S N Steen, et al.
Journal of Lipid Research
|
March 1, 1996
Rat hepatoma L35 cells, a liver-differentiated cell line, display resistance to bile acid repression of cholesterol 7 alpha-hydroxylase
J D Trawick, K D Lewis, S Dueland, et al.
Investigational New Drugs
|
March 15, 2012
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
A Dasari, L Gore, W A Messersmith, et al.
MCN. the American Journal of Maternal Child Nursing
|
January 1, 1996
13 nurses tell us, why i'm proud to be an MCH nurse
M Biancuzzo, M K Kachoyeanos, J K Leavitt, et al.
ESMO Open
|
October 29, 2021
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up
S P D'Angelo, S Bhatia, A S Brohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2022
Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAF<sup>V600</sup> mutation-positive melanoma
C Robert, K D Lewis, R Gutzmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF<sup>v600</sup> mutation-positive melanoma receiving adjuvant vemurafenib
P A Ascierto, K D Lewis, A M Di Giacomo, et al.
Page
of 3